Literature DB >> 22267770

Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Carlos A Vaz Fragoso1, John Concato, Gail McAvay, Peter H Van Ness, Thomas M Gill.   

Abstract

The aim of the present study was to evaluate, among older persons, the association between respiratory impairment and hospitalisation for chronic obstructive pulmonary disease (COPD), based on spirometric Z-scores, i.e. the LMS (lambda, mu, sigma) method, and a competing risk approach. Using data on 3,563 white participants aged 65-80 yrs (from the Cardiovascular Health Study) we evaluated the association of LMS-defined respiratory impairment with the incident of COPD hospitalisation and the competing outcome of death without COPD hospitalisation, over a 5-yr period. Respiratory impairment included airflow limitation (mild, moderate or severe) and restrictive pattern. Over a 5-yr period, 276 (7.7%) participants had a COPD hospitalisation incident, whereas 296 (8.3%) died without COPD hospitalisation. The risk of COPD hospitalisation was elevated more than two-fold in LMS-defined mild and moderate airflow limitation and restrictive pattern (adjusted HR (95% CI): 2.25 (1.25-4.05), 2.54 (1.53- 4.22) and 2.65 (1.82-3.86), respectively), and more than eight-fold in LMS-defined severe airflow limitation (adjusted HR (95% CI) 8.33 (6.24-11.12)). Conversely, only LMS-defined restrictive-pattern was associated with the competing outcome of death without COPD hospitalisation (adjusted HR (95% CI) 1.68 (1.22-2.32)). In older white persons, LMS-defined respiratory impairment is strongly associated with an increased risk of COPD hospitalisation. These results support the LMS method as a basis for defining respiratory impairment in older persons.

Entities:  

Mesh:

Year:  2012        PMID: 22267770      PMCID: PMC3773173          DOI: 10.1183/09031936.00128711

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  54 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations.

Authors:  Robert Vassallo; Eric A Jensen; Thomas V Colby; Jay H Ryu; William W Douglas; Thomas E Hartman; Andrew H Limper
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

3.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

4.  Lung function and risk of myocardial infarction and sudden cardiac death.

Authors:  G D Friedman; A L Klatsky; A B Siegelaub
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

5.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

6.  Predicted values: how should we use them?

Authors:  M R Miller; A C Pincock
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

Review 7.  Clinical use of bone densitometry: scientific review.

Authors:  Steven R Cummings; David Bates; Dennis M Black
Journal:  JAMA       Date:  2002-10-16       Impact factor: 56.272

8.  Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.

Authors:  Irem S Patel; Ioannis Vlahos; Tom M A Wilkinson; Simon J Lloyd-Owen; Gavin C Donaldson; Mark Wilks; Rodney H Reznek; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2004-05-06       Impact factor: 21.405

9.  A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory.

Authors:  Christine A Glady; Shawn D Aaron; Mary Lunau; Jennifer Clinch; Robert E Dales
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

10.  Thoracic kyphosis and ventilatory dysfunction in unselected older persons: an epidemiological study in Dicomano, Italy.

Authors:  Mauro Di Bari; Melisenda Chiarlone; Daniela Matteuzzi; Simona Zacchei; Claudia Pozzi; Vincenzo Bellia; Francesca Tarantini; Riccardo Pini; Giulio Masotti; Niccoló Marchionni
Journal:  J Am Geriatr Soc       Date:  2004-06       Impact factor: 5.562

View more
  19 in total

1.  Aging-Related Considerations When Evaluating the Forced Expiratory Volume in 1 Second (FEV1) Over Time.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Peter H Van Ness; E Jeffrey Metter; Luigi Ferrucci; H Klar Yaggi; John Concato; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-02       Impact factor: 6.053

2.  Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.

Authors:  Brian S Marcus; Gail McAvay; Thomas M Gill; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2015-01-30       Impact factor: 5.562

3.  Spirometry, Static Lung Volumes, and Diffusing Capacity.

Authors:  Carlos A Vaz Fragoso; Hilary C Cain; Richard Casaburi; Patty J Lee; Lynne Iannone; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Care       Date:  2017-07-11       Impact factor: 2.258

4.  Comment on: Wollmer P, Engström G. Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC: An outcome study. Respiratory Medicine (2013) 107, 1460-1462.: Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC.

Authors:  Carlos A Vaz Fragoso; Jeffrey J Pretto; Philip H Quanjer
Journal:  Respir Med       Date:  2015-05-02       Impact factor: 3.415

5.  Respiratory impairment and dyspnea and their associations with physical inactivity and mobility in sedentary community-dwelling older persons.

Authors:  Carlos A Vaz Fragoso; Daniel P Beavers; John L Hankinson; Gail Flynn; Kathy Berra; Stephen B Kritchevsky; Christine K Liu; Mary M McDermott; Todd M Manini; W Jack Rejeski; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

6.  Re-evaluation of the Uplift Clinical Trial Using Age-Appropriate Spirometric Criteria.

Authors:  Carlos A Vaz Fragoso; Linda S Leo-Summers; Thomas M Gill; Gail J McAvay
Journal:  Chest       Date:  2020-04-09       Impact factor: 9.410

7.  The subsequent course of disability in older persons discharged to a skilled nursing facility after an acute hospitalization.

Authors:  Zuyun Liu; Ling Han; Linda Leo-Summers; Evelyne A Gahbauer; Heather G Allore; Thomas M Gill
Journal:  Exp Gerontol       Date:  2017-08-04       Impact factor: 4.032

8.  Spirometric Criteria for Chronic Obstructive Pulmonary Disease in Clinical Trials of Pharmacotherapy.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  COPD       Date:  2018-02       Impact factor: 2.409

9.  Re-evaluation of combination therapy in chronic obstructive pulmonary disease (COPD).

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Linda S Leo-Summers; Peter H Van Ness
Journal:  Respir Med       Date:  2019-03-29       Impact factor: 3.415

Review 10.  Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) in Aging Populations.

Authors:  Carlos A Vaz Fragoso
Journal:  COPD       Date:  2015-12-02       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.